Ocugen, Inc.

OCGN · Biological Products, (No Diagnostic Substances)

Chemicals and Allied Products boards →

Directors

Avg Age

4.8

Avg Tenure (yrs)

83%

Independent

Independent Non-independent Near rotation

Board Members

Shankar Musunuri, Ph.D., MBA Chair

Blaise Coleman, MBA Director

...and 4 more directors

The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.

Get Seats Opening

Source: SEC DEF 14A proxy statement filed 2026-04-28. Data extracted and structured by FindABoardSeat.